BamSEC and AlphaSense Join Forces
Learn More

Spyre Therapeutics Inc. – Underwriting Agreements

NASDAQ: SYRE    
Share price (6/2/26): $69.16    
Market cap (6/2/26): $6.006 billion
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 45 pages Spyre Therapeutics, Inc. 6,500,000 Shares of Common Stock, Par Value $0.0001 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Spyre Therapeutics, Inc. 14,864,865 Shares of Common Stock, Par Value $0.0001 Underwriting Agreement
12/34/56
EX-1.2
from S-3 41 pages Spyre Therapeutics, Inc. $200,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 46 pages Spyre Therapeutics, Inc. 7,275,000 Shares of Common Stock, Par Value $0.0001 Underwriting Agreement
12/34/56
EX-1.2
from S-3 41 pages Spyre Therapeutics, Inc. $200,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 35 pages Aeglea Biotherapeutics, Inc. Common Stock ($0.0001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from 8-K 54 pages Aeglea Biotherapeutics, Inc. 11,652,830 Shares of Common Stock, Par Value $0.0001 Pre-Funded Warrants to Purchase 13,610,328 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 34 pages Aeglea Biotherapeutics, Inc. Common Stock ($0.0001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from 8-K 57 pages Aeglea Biotherapeutics, Inc. 3,750,000 Shares of Common Stock, Par Value $0.0001 Pre-Funded Warrants to Purchase 3,750,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 41 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 47 pages 4,500,000 Shares Aeglea Biotherapeutics, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 33 pages Underwriting Agreement 3,000,000 Shares Aeglea Biotherapeutics, Inc. Common Stock ($0.0001 Par Value) Equity Underwriting Agreement
12/34/56
EX-1.2
from S-3 42 pages Aeglea Biotherapeutics, Inc. Common Stock ($0.0001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from S-1/A 51 pages [ ] Shares Aeglea Biotherapeutics, Inc. Common Stock Underwriting Agreement
12/34/56